Outcome Analysis of POEM and Endoluminal Therapies
Launched by UNIVERSITY OF CALIFORNIA, DAVIS · Apr 17, 2017
Trial Information
Current as of July 24, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Over the last few years there have been numerous advances in the use of endoscopic equipment and related treatments in the identification and intervention of gastrointestinal diseases. Many of these treatments using flexible endoscopes have either complimented or replaced surgical approaches to these same benign and malignant disease processes with the potential of being the standard of care for many of these clinical conditions. The initial primary focus of this study will be the use of endoscopic myotomy for achalasia, endoscopic treatment of post bariatric weight gain, endoscopic gastro-...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult male and female patients 18-80 years of age
- • Meet the criteria for surgery of benign and/or malignant gastrointestinal pathology(s)
- • Gastrointestinal Reflux Disease
- • Achalasia
- • Barrett's Esophagus
- • Post Bariatric Surgery conditions
- • Other gastrointestinal and postsurgical disorders.
- Exclusion Criteria:
- • Adults unable to consent
- • Individuals that do not meet inclusion criteria or qualify for endoluminal treatment paradigms and internees.
About University Of California, Davis
The University of California, Davis (UC Davis) is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials and studies. With a strong focus on interdisciplinary collaboration, UC Davis leverages its extensive expertise in medical research, education, and patient care to drive breakthroughs in various fields, including medicine, public health, and agriculture. The university's clinical trial programs emphasize rigorous scientific methodology and ethical standards, aiming to translate research findings into impactful treatments and improved patient outcomes. Through its state-of-the-art facilities and a dedicated team of researchers and healthcare professionals, UC Davis is at the forefront of transforming healthcare practices and addressing critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sacramento, California, United States
Patients applied
Trial Officials
Mohamed R Ali, MD
Principal Investigator
U.C. Davis Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials